Senior insider sale
Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$3.13M
32.92K shares
What this filing means
SHULMAN JOSEPH plans to sell 32.92K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $3.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2025ACC: 0001950047-25-006666
Officer· Chief Technical Officer
Since Feb 2022
32.92K
Shares to sell
$3.13M
Approx. market value
16.78K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/2/2025
16.78KTotal acquired16.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2025 | Exercise of Stock Options Cash | 16.78K | — |
| Total | 16.78K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.19K
Market value
$419.1K
8/21/2025
—Completed
Units to sell
3.98K
Market value
$358.9K
8/11/2025
—Completed
Units to sell
7.97K
Market value
$619.9K
7/9/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.78K
Market value
$1.73M
9/2/2025
Total
Units
32.92K
Value
$3.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2025 | 4.19K | $419.1K | — | Completed |
8/11/2025 | 3.98K | $358.9K | — | Completed |
7/9/2025 | 7.97K | $619.9K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2025 | 16.78K | $1.73M | NASDAQ | Planned |
| Total | 32.92K | $3.13M | ||